Should You Buy Codexis Inc (CDXS) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
CDXS is not a good buy right now for a beginner long-term investor with $50k–$100k who wants to act immediately. The stock is in a strong downtrend (bearish moving averages + worsening MACD) and the latest quarter shows sharp revenue decline with continued losses. With no supportive Intellectia signals today and no near-term positive news catalysts, the odds favor further downside/volatility rather than a clean long-term entry at this moment.
Technical Analysis
Trend is bearish and weakening. Price (1.33) is below key levels and the moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating sustained downside momentum. MACD histogram is negative (-0.0326) and expanding lower, confirming accelerating bearish momentum. RSI_6 is ~21.6, which is oversold and can produce short bounces, but oversold conditions alone are not a reliable long-term entry signal when the broader trend is down. Key levels: pivot 1.601 (well above current price); support zone is S2 ~1.23 (next major support). The stock is also trading below/around S1 1.372, suggesting a prior support break.
Intellectia Proprietary Trading Signals
- [AI Stock Picker](module://ai_stock_pick): no signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Analyst Ratings and Price Target Trends
No analyst rating/price target change data was provided in the dataset, so a recent Wall Street upgrade/downgrade trend cannot be confirmed here. Based on the available fundamentals (shrinking revenue, continued losses) versus the one positive (higher gross margin), the likely 'pro' view would focus on operational efficiency/turnaround potential, while the 'con' view would emphasize declining sales and lack of clear near-term catalysts. Politician/congress trading: no recent congress trading data available; hedge fund and insider trading trends are reported as neutral.
Wall Street analysts forecast CDXS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CDXS is 6 USD with a low forecast of 2 USD and a high forecast of 11 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast CDXS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CDXS is 6 USD with a low forecast of 2 USD and a high forecast of 11 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 1.290
Current: 1.290
No data
